CSNK2A1 Foundation
Jennifer Sills is a legal professional and entrepreneur with extensive experience in nonprofit leadership and venture capital. As the Founder and President of the CSNK2A1 Foundation since January 2018, Jennifer Sills leads efforts to find a cure for Okur-Chung Neurodevelopmental Syndrome and supports affected individuals. Co-founding Park Bench Capital in December 2017, Jennifer Sills focuses on investing in diverse startup companies and has actively engaged in initiatives to empower women in angel investing. Prior legal experience includes serving as an Estate Planning and Tax Attorney at Coblentz Patch Duffy & Bass LLP and Berliner Cohen, LLP. Jennifer Sills holds a Doctor of Law (JD) from Pepperdine Law and a Bachelor of Arts in English Language and Literature from the University of California, Berkeley.
This person is not in any teams
CSNK2A1 Foundation
CSNK2A1 Foundation is focused on finding a cure for Okur-Chung Neurodevelopmental Syndrome and ensuring affected individuals have the opportunities and supports necessary for happy and full lives. CSNK2A1 Foundation is operated and funded through a committed team of volunteers, advocates and researchers. We aim to accomplish our mission by: * financing and encouraging meaningful research, * providing support to individuals affected and those that care for and love them, * promoting awareness, * educating patients, caregivers and health professionals and * advocating for issues important to our community. Okur-Chung Neurodevelopmental Syndrome is a rare genetic disorder first identified in 2016. OCNDS is caused by a mutation in the CSNK2A1 gene which is located on Chromosome 20. The gene CSNK2A1 creates a protein called CK2 which plays a crucial role in development. A mutation in this gene disrupts typical development. CSNK2A1 Foundation is a 501(c)(3) non-profit organization. EIN #82-4220939